Intermediate versus hard end points in clinical trials on hypertension

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.

Original languageEnglish
Pages (from-to)294-297
Number of pages4
JournalCurrent Hypertension Reports
Volume7
Issue number4
Publication statusPublished - Aug 2005

Fingerprint

Randomized Controlled Trials
Outcome Assessment (Health Care)
Clinical Trials
Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Intermediate versus hard end points in clinical trials on hypertension. / Grassi, Guido.

In: Current Hypertension Reports, Vol. 7, No. 4, 08.2005, p. 294-297.

Research output: Contribution to journalArticle

@article{12fd1af2fa414a0b82d049cae4a3676a,
title = "Intermediate versus hard end points in clinical trials on hypertension",
abstract = "The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.",
author = "Guido Grassi",
year = "2005",
month = "8",
language = "English",
volume = "7",
pages = "294--297",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Intermediate versus hard end points in clinical trials on hypertension

AU - Grassi, Guido

PY - 2005/8

Y1 - 2005/8

N2 - The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.

AB - The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.

UR - http://www.scopus.com/inward/record.url?scp=24944494144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944494144&partnerID=8YFLogxK

M3 - Article

C2 - 16061049

AN - SCOPUS:24944494144

VL - 7

SP - 294

EP - 297

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 4

ER -